Ten months later, he went blind in his left eye as well
Asimakidou, Evridiki, Richard Reynolds, Anna M
CagriSema's Advantages: First to Market: 6-12 month head start Leverages Wegovy Success: Built-in brand recognition Proven Semaglutide Component: Half the drug is already approved Strong Diabetes Data: Positions for dual indication No Dysesthesia: Cleaner safety profile in one key area Retatrutide's Advantages: Higher Efficacy: 28.7% vs 20.4% (8.3 points more) Superior BP Reduction: -14 mmHg vs likely similar to semaglutide Single Molecule: Potentially easier manufacturing Multiple Indications: OA, OSA, obesity, diabetes trials Novel Class: First triple agonist = strong IP protection The Verdict: Market Will Support Both These medications won't compete head-to-head
One study suggests that, due to glutathiones antioxidant activity, supplementing with glutathione has been found to increase skin collagen deposition, while keeping the negative influence, such as nitric oxide synthase, under control
With dedication and expert support, maintaining your health goals is possible
Stopping may lead to loss of blood sugar control and, in some cases, return of appetite or weight regain